Vexus ultrasound to set dry weight in dialysis
Part of Kidney & urinary clinical trials.
This trial uses a special ultrasound scan (VEXUS) to help doctors find the right 'dry weight' for people on hemodialysis. The goal is to remove just the right amount of fluid without strain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on dialysis for kidney failure for at least 3 months.
- You are treated at the Medical Research Institute or Faculty of Medicine, Alexandria University.
- You are between 25 and 65 years old.
- You are able to understand and agree to take part (give consent).
- Your body mass index (BMI) is under 30.
- You do not have certain heart, lung, or liver conditions (like right heart problems, COPD, or cirrhosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to manage fluids in patients with acute kidney injury who are receiving a type of dialysis called continuous renal replacement therapy. The method uses ultrasound to check blood flow in the veins and kidneys to guide fluid decisions, which may help recovery.
This study uses ultrasound imaging of the heart to predict which patients may have sudden drops in blood pressure when starting a type of dialysis called CVVHDF. The goal is to help doctors better manage patients during this procedure, which may reduce complications.
This study uses an ultrasound to check how much your main vein (inferior vena cava) collapses during dialysis. It aims to see if this measurement can help predict drops in blood pressure during treatment, so doctors can better manage your dialysis sessions.
This trial tests if using a special ultrasound score (VeXUS) to guide fluid removal can improve recovery in patients with acute kidney injury after heart surgery. It compares this approach to standard care to see if it leads to better outcomes.
This trial tests a special type of ultrasound placed inside a blood vessel to better understand problems with dialysis access. It may help doctors find the cause of access malfunction during your diagnostic fistulogram.
This trial tests whether using ultrasound guidance (VEXUS) can help prevent or treat acute kidney injury after heart surgery. If you develop kidney problems in the first two days after your operation, you may be able to join.
Hear when a new Hemodialysis Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.